vancomycin has been researched along with flomoxef in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, H; Matsumoto, M; Shitsuta, T; Tsubouchi, H; Tsuji, K; Yasumura, K | 1 |
| Hamamoto, H; Kurokawa, K; Lee, BL; Maki, H; Matsuo, M; Murakami, K; Nishida, S; Sekimizu, K; Yamane, N | 1 |
| Simon, C; Simon, M | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Suzuki, Y; Yokota, N | 1 |
| Harauchi, T; Hirata, M; Itoh, F; Mizushima, Y; Sato, K | 1 |
| Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S | 1 |
| Nakagawa, Y; Toyoguchi, T | 1 |
| Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 1 |
| Barinov, SM; Hasegawa, M; Komlev, VS; Sudo, A; Uchida, A | 1 |
9 other study(ies) available for vancomycin and flomoxef
| Article | Year |
|---|---|
Synthesis and biological evaluation of a series of new parenteral optically active 3-[[(N-alkylpyridinium-4'-yl)thio]methyl]-2-oxaisocephems.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Stereoisomerism | 1995 |
Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model.
Topics: Animals; Anti-Bacterial Agents; Bombyx; Cephalosporins; Chloramphenicol; Cycloserine; Inhibitory Concentration 50; Larva; Microbial Sensitivity Tests; Staphylococcus aureus; Tetracycline; Vancomycin | 2009 |
In vitro activity of flomoxef and cefazolin in combination with vancomycin.
Topics: Cefazolin; Cephalosporins; Drug Therapy, Combination; Microbial Sensitivity Tests; Vancomycin | 1991 |
[Biological types and drug-sensitivities of multiple strains of freshly isolated methicillin-resistant Staphylococcus aureus].
Topics: Cefamandole; Cephalosporins; Cephalothin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1991 |
[Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Kidney; Male; Moxalactam; Rats; Rats, Sprague-Dawley; Vancomycin | 1995 |
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin | 1993 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Cephalosporins; Delayed-Action Preparations; Drug Carriers; Durapatite; Female; Femur; Gentamicins; Microscopy, Electron, Scanning; Nanostructures; Porosity; Prostheses and Implants; Rabbits; Vancomycin | 2004 |